These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1149783)
1. Differences among hyperlipoproteinaemic subjects in the response of lipoprotein lipids to resin therapy. Miller NE; Nestel PJ Eur J Clin Invest; 1975 Jun; 5(3):241-7. PubMed ID: 1149783 [TBL] [Abstract][Full Text] [Related]
2. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin. Rose HG; Haft GK; Juliano J Atherosclerosis; 1976; 23(3):413-27. PubMed ID: 178325 [TBL] [Abstract][Full Text] [Related]
3. The effects of colestipol on the metabolism of very-low-density lipoproteins in man. Witztum JL; Schonfeld G; Weidman SW J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544 [TBL] [Abstract][Full Text] [Related]
4. Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. Kłosiewicz-Latoszek L; Szostak WB Eur J Clin Pharmacol; 1991; 40(1):33-41. PubMed ID: 2060543 [TBL] [Abstract][Full Text] [Related]
5. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia. Simons LA; Hickie JB; Balasubramaniam S Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229 [TBL] [Abstract][Full Text] [Related]
6. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia. Crouse JR; Grundy SM Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561 [TBL] [Abstract][Full Text] [Related]
7. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia. Olsson AG; Rössner S; Walldius G; Carlson LA Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607 [TBL] [Abstract][Full Text] [Related]
8. Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemia. Durrington PN; Bolton CH; Hartog M Clin Chim Acta; 1978 Jan; 82(1-2):151-60. PubMed ID: 201398 [TBL] [Abstract][Full Text] [Related]
9. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias. Carlson LA; Olsson G; Ballantyne D Atherosclerosis; 1977 Apr; 26(4):603-9. PubMed ID: 193526 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia. Vessby B; Hedstrand H; Olsson U Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321 [TBL] [Abstract][Full Text] [Related]
11. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man. Goodman DS; Noble RP; Dell RB J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058 [TBL] [Abstract][Full Text] [Related]
12. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia. Nikkilä EA; Ylikahri R; Huttunen JK Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608 [TBL] [Abstract][Full Text] [Related]
13. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil. Sommariva D; Branchi A; Pini C; Scandiani L; Orlandi S; Fasoli A Int J Clin Pharmacol Res; 1988; 8(5):383-92. PubMed ID: 3068163 [TBL] [Abstract][Full Text] [Related]
14. Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man. Miller NE; Nestel PJ; Clifton-Bligh P Atherosclerosis; 1976; 23(3):535-47. PubMed ID: 178328 [TBL] [Abstract][Full Text] [Related]
15. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes. Olsson AG; Ekelund LG; Carlson LA Acta Med Scand; 1975; 198(1-2):55-73. PubMed ID: 170796 [TBL] [Abstract][Full Text] [Related]
16. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia. Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203 [TBL] [Abstract][Full Text] [Related]
17. Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia. Olsson AG; Rössner S; Walldius G; Carlson LA; Lang PD Atherosclerosis; 1977 Jul; 27(3):279-87. PubMed ID: 901625 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein fractions in idiopathic hyperlipoproteinaemia. Kłosiewicz-Latoszek L; Naruszewicz M; Cybulska B; Szostak WB; Chotkowska E Acta Physiol Pol; 1982; 33(1-2):47-56. PubMed ID: 7158380 [TBL] [Abstract][Full Text] [Related]
19. Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia. Kłosiewicz-Latoszek L; Nowicka G; Szostak WB; Naruszewicz M Atherosclerosis; 1987 Feb; 63(2-3):203-9. PubMed ID: 3827981 [TBL] [Abstract][Full Text] [Related]
20. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin. Glueck CJ; Fallat RW; Mellies M; Tsang RC Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]